Brekke, Kurt Richard 1969-
Brekke, Kurt Richard
Brekke, Kurt R.
Kurt R. Brekke
VIAF ID: 7203351 ( Personal )
Permalink: http://viaf.org/viaf/7203351
Preferred Forms
- 100 1 _ ‡a Brekke, Kurt R.
- 100 1 _ ‡a Brekke, Kurt Richard
-
- 100 1 _ ‡a Brekke, Kurt Richard
-
-
- 100 0 _ ‡a Kurt R. Brekke
4xx's: Alternate Name Forms (6)
5xx's: Related Names (4)
- 551 _ _ ‡a Bergen ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Norges Handelshøyskole
- 510 2 _ ‡a Norges Handelshøyskole (NHH) / Institutt for samfunnsøkonomi
- 510 2 _ ‡a Norges handelshøyskole ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Capital taxation and imperfect competition ACE vs. CBIT | |
Competition and physician behaviour: Does the competitive environment affect the propensity to issue sickness certificates? | |
Competition and waiting times in hospital markets | |
Competition in regulated markets with sluggish beliefs about quality | |
Direct to consumer advertising in pharmaceutical markets | |
Ekskluderende vertikale bindinger og linære tariffer i franchisekontrakter : en studie av det norske bilmarkedet | |
Er legemidler fremdeles billig i Norge? : en sammenligning av priser på reseptpliktige legemidler mellom Norge og ni vest-europeiske land | |
Evaluering av ny apoteklov og indeksprissystemet | |
Five essays on competition and regulation in health care markets | |
Fra forvaltning til monopol i den norske sykehussektoren | |
Gatekeeping in health care | |
Hospital competition in the national health service: Evidence from a patient choice reform | |
Hospital reimbursement in an oligopolistic industry | |
How does the type of remuneration affect physician behaviour? Fixed salary versus free-for-service | |
Margins and market shares pharmacy incentives for generic substitution | |
Offentlig sektor som tilbyder eller produsent? : noen synspunkter på oppgavefordeling mellom privat og offentlig sektor | |
Patient mobility, health care quality and welfare | |
Pharmaceutical patents : incentives for R&D or marketing? | |
Price and quality in spatial competition | |
Prices of pharmaceuticals : a comparison of prescription drug prices in Sweden with nine European countries | |
Pris- og avanseregulering i legemiddelmarkedet : en prinsipiell diskusjon og en vurdering av den norske modellen | |
Public versus private health care in a national health service | |
Qualitäts- und Standortwahl bei Preisregulierung | |
Quality and location choices under price regulation | |
Quality competition with profit constraints | |
Regulation and pricing of pharmaceuticals: reference pricing or price cap regulation? |